Detalhe da pesquisa
1.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 401(10390): 1773-1785, 2023 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086745
2.
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Clin Transl Oncol
; 25(9): 2647-2664, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326826
3.
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.
Cancers (Basel)
; 14(19)2022 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230628
4.
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Breast
; 66: 77-84, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206609
5.
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Clin Transl Oncol
; 26(2): 555-556, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37902930
6.
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.
J Drug Assess
; 8(1): 62-69, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31069129
7.
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)
Clin. transl. oncol. (Print)
; 25(9): 2647-2664, sept. 2023. ilus, tab
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-224131
8.
[Euthanasia in patients with cancer and the continuous-care providers]. / La eutanasia en el paciente con cáncer y los cuidados continuos.
Clin Transl Oncol
; 7(7): 278-84, 2005 Aug.
Artigo
em Espanhol
| MEDLINE | ID: mdl-16185589
9.
Cuando una paciente con cáncer de mama metastásica luminal A es subsidiaria de quimioterapia en primera línea / Outcome in a patient with luminal A metastatic breast cancer suitable for first-line chemotherapy
Rev. senol. patol. mamar. (Ed. impr.)
; 29(2): 92-93, abr.-jun. 2016. ilus
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-153250
10.
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)
Clin. transl. oncol. (Print)
; 26(2): 555-556, feb. 2024.
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-230201
11.
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.
Clin Transl Oncol
; 11(11): 727-36, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19917536
12.
La eutanasia en el paciente con cáncer y los cuidados continuos / Euthanasia in patients with cancer and the continuous-care providers
Clin. transl. oncol. (Print)
; 7(7): 278-284, ago. 2005.
Artigo
em Es
| IBECS (Espanha) | ID: ibc-040771